Hou M - Search Results

1

[Efficacy and safety of IA regimen containing different doses of idarubicin in de-novo acute myeloid leukemia for adult patients].

Sun AN, Tian XP, Cao XS, Ouyang J, Gu J, Xu KL, Yu K, Zeng QS, Sun ZM, Chen GA, Gao SJ, Zhou J, Wang JH, Yang LH, Luo JM, Zhang M, Guo XH, Wang XM, Zhang X, Shi KQ, Sun H, Ding XM, Hu JD, Zheng RJ, Zhao HG, Hou M, Wang X, Chen FP, Zhu Y, Liu H, Huang DP, Liao AJ, Ma LM, Su LP, Liu L, Zhou ZP, Huang XB, Sun XM, Wu DP. Sun AN, et al. Among authors: hou m. Zhonghua Xue Ye Xue Za Zhi. 2017 Dec 14;38(12):1017-1023. doi: 10.3760/cma.j.issn.0253-2727.2017.12.003. Zhonghua Xue Ye Xue Za Zhi. 2017. PMID: 29365393 Free PMC article. Chinese.

2

[The diagnostic value of platelet glycoprotein-specific autoantibody detection in autoimmune thrombocytopenic purpura].

Li W, Hou M, Zhang M, Zhu Y, Ma D. Li W, et al. Among authors: hou m. Zhonghua Xue Ye Xue Za Zhi. 2001 Jul;22(7):374-6. Zhonghua Xue Ye Xue Za Zhi. 2001. PMID: 11877102 Chinese.

3

Mycophenolate mofetil (MMF) for the treatment of steroid-resistant idiopathic thrombocytopenic purpura.

Hou M, Peng J, Shi Y, Zhang C, Qin P, Zhao C, Ji X, Wang X, Zhang M. Hou M, et al. Eur J Haematol. 2003 Jun;70(6):353-7. doi: 10.1034/j.1600-0609.2003.00076.x. Eur J Haematol. 2003. PMID: 12756016 Clinical Trial.

4

[Study on autoimmune thrombocytopenic purpura related antibody].

Lu L, Hou M, Shi Y, Qin P, Peng J, Zhu YY, Zhang MH. Lu L, et al. Among authors: hou m. Zhonghua Xue Ye Xue Za Zhi. 2003 Sep;24(9):477-9. Zhonghua Xue Ye Xue Za Zhi. 2003. PMID: 14575592 Chinese.

5

[The diagnostic value of platelet glycoprotein-specific autoantibody detection in idiopathic thrombocytopenic purpura].

Zhang HY, Hou M, Zhang XH, Guan XH, Sun GZ. Zhang HY, et al. Among authors: hou m. Zhongguo Shi Yan Xue Ye Xue Za Zhi. 2004 Apr;12(2):204-6. Zhongguo Shi Yan Xue Ye Xue Za Zhi. 2004. PMID: 15157334 Chinese.

6

Expression of survivin and bax/bcl-2 in peroxisome proliferator activated receptor-gamma ligands induces apoptosis on human myeloid leukemia cells in vitro.

Liu JJ, Huang RW, Lin DJ, Peng J, Wu XY, Lin Q, Pan XL, Song YQ, Zhang MH, Hou M, Chen F. Liu JJ, et al. Among authors: hou m. Ann Oncol. 2005 Mar;16(3):455-9. doi: 10.1093/annonc/mdi077. Epub 2005 Jan 10. Ann Oncol. 2005. PMID: 15642706 Free article.

7

Antiproliferation effects of ponicidin on human myeloid leukemia cells in vitro.

Liu JJ, Huang RW, Lin DJ, Wu XY, Lin Q, Peng J, Pan X, Song YQ, Zhang MH, Hou M, Chen F. Liu JJ, et al. Among authors: hou m. Oncol Rep. 2005 Apr;13(4):653-7. Oncol Rep. 2005. PMID: 15756438

8

Oridonin-induced apoptosis in leukemia K562 cells and its mechanism.

Liu JJ, Huang RW, Lin DJ, Wu XY, Peng J, Pan XL, Song YQ, Lin Q, Hou M, Wang DN, Chen F, Zhang MH. Liu JJ, et al. Among authors: hou m. Neoplasma. 2005;52(3):225-30. Neoplasma. 2005. PMID: 15875084

9

[Study on the direct MAIPA technique in the differential diagnosis of immune and non-immune thrombocytopenia].

Qin P, Hou M, Sun JZ, Lu L, Shi Y, Zhu YY, Li LZ, Zhang MH. Qin P, et al. Among authors: hou m. Zhonghua Xue Ye Xue Za Zhi. 2005 Mar;26(3):167-9. Zhonghua Xue Ye Xue Za Zhi. 2005. PMID: 15946531 Chinese.

10

Aclarubicin and low-dose Cytosine arabinoside in combination with granulocyte colony-stimulating factor in treating acute myeloid leukemia patients with relapsed or refractory disease and myelodysplastic syndrome: a multicenter study of 112 Chinese patients.

Li JM, Shen Y, Wu DP, Liang H, Jin J, Chen FY, Song YP, Song EY, Qiu XF, Hou M, Qiu ZC, Shen ZX. Li JM, et al. Among authors: hou m. Int J Hematol. 2005 Jul;82(1):48-54. doi: 10.1532/IJH97.A10424. Int J Hematol. 2005. PMID: 16105759 Clinical Trial.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

3,739 results

Search Page

Filters